Evidence map›Paper›PMID 15113893›Full record

ArticleJournal of virology2004

Cellular repressor inhibits human cytomegalovirus transcription from the UL127 promoter.

Philip E Lashmit, Christopher A Lundquist, Jeffery L Meier, Mark F Stinski

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. RNA-targeted proteomics identifies YBX1 as critical for efficient HCMV mRNA translation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Philip E LashmitDepartment of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Christopher A Lundquist
Jeffery L Meier
Mark F Stinski
University of Iowa · US

Funding

THE GENES THAT REGULATE HUMAN CYTOMEGALOVIRUS EXPRESSIONR01AI013562 · NIAID · UNIVERSITY OF IOWA · PI STINSKI, MARK F · 1985 to 2005
$1.4M
REGULATION OF HUMAN CYTOMEGALOVIRUS GENE EXPRESSIONR21AI013562 · NIAID · UNIVERSITY OF IOWA · PI STINSKI, MARK F · 2000 to 2000
$294k
REGULATION OF CYTOMEGALOVIRUS INFECTION OF MONOCYTESR29AI040130 · NIAID · UNIVERSITY OF IOWA · PI MEIER, JEFFERY L · 1997 to 2001
$206k
BLRD VA I01 BX001107NIAID NIH HHS AI 13562NIAID NIH HHS AI 40130NIAID NIH HHS R01 AI013562NIAID NIH HHS R21 AI013562
6 · The paper itself

Abstract

The region of the human cytomegalovirus (HCMV) genome between the UL127 promoter and the major immediate-early (MIE) enhancer is referred to as the unique region. The role of this region during a viral infection is not known. In wild-type HCMV-infected permissive fibroblasts, there is no transcription from the UL127 promoter at any time during productive infection. Our investigators previously reported that the region upstream of the UL127 TATA box repressed expression from the UL127 promoter (C. A. Lundquist et al., J. Virol. 73:9039-9052, 1999). The region was reported to contain functional NF1 DNA binding sites (L. Hennighausen and B. Fleckenstein, EMBO J. 5:1367-1371, 1986). Sequence analysis of this region detected additional consensus binding sites for three transcriptional regulatory proteins, FoxA (HNF-3), suppressor of Hairy wing, and CAAT displacement protein. The cis-acting elements in the unique region prevented activation of the early UL127 promoter by the HCMV MIE proteins. In contrast, deletion of the region permitted very high activation of the UL127 promoter by the viral MIE proteins. Mutation of the NF1 sites had no effect on the basal activity of the promoter. To determine the role of the other sites in the context of the viral genome, recombinant viruses were generated in which each putative repressor site was mutated and the effect on the UL127 promoter was analyzed. Mutation of the putative Fox-like site resulted in a significant increase in expression from the viral early UL127 promoter. Insertion of wild-type Fox-like sites between the HCMV immediate-early (IE) US3 TATA box and the upstream NF-kappaB-responsive enhancer (R2) also significantly decreased gene expression, but mutated Fox-like sites did not. The wild-type Fox-like site inhibits activation of a viral IE enhancer-containing promoter. Cellular protein, which is present in uninfected or infected permissive cell nuclear extracts, binds to the wild-type Fox-like site but not to mutated sites. Reasons for repression of UL127 gene transcription during productive infection are discussed.

Indexed as

Promoter Regions, GeneticBase SequenceBinding SitesCells, CulturedCytomegalovirusGenes, Immediate-EarlyHumansMolecular Sequence DataRepressor ProteinsTranscription, GeneticRepressor Proteins

Identifiers

PMID15113893
PMCPMC400324
OpenAlexW2156853081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.